Identification of pyrazine-based TrkA inhibitors: design, synthesis, evaluation, and computational modeling studies

Area of Science:

• Neuroscience
• Pharmacology
• Oncology

Background:

• Trk receptors, particularly TrkA, are crucial for neuronal function.
• TrkA signaling is implicated in tumor growth, pain, and chemoresistance.

Purpose of the Study:

• To identify novel inhibitors of TrkA.
• To explore the structure-activity relationship (SAR) of pyrazine-based TrkA inhibitors.

Main Methods:

• Computational screening to identify a Trk active pharmacophore.
• Synthesis and testing of pyrazine-based compounds as TrkA inhibitors.
• Screening against a tyrosine kinase panel.
• Analysis of predicted binding modes.

Main Results:

• A novel Trk active pharmacophore was identified.
• Pyrazine-based inhibitors potently inhibited TrkA.
• Inhibitors showed highest activity against TrkA in a kinase panel.
• Non-linear SAR was observed, with exploitable regions identified for future optimization.

Conclusions:

• Novel pyrazine-based compounds are potent TrkA inhibitors.
• These inhibitors represent a promising starting point for developing therapeutics for TrkA-mediated conditions.
• Further development based on predicted binding modes could lead to advanced inhibitors.